Recall Record

Houston, TX, United States

Advanced Pharma Inc. recalls

8 recalls recorded since 2018, most recently on 26 April 2019. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls8
Ongoing (FDA)0
Terminated or completed8
Class I (FDA)2

Terminated Class II Drugs

Recall started
26 April 2019
Terminated
30 October 2019
Reason
Sub-potency
Distribution
Nationwide in the US
Initiated
Voluntary: Firm initiated
Recall number
D-1251-2019

Terminated Class II Drugs

Recall started
13 March 2019
Terminated
14 January 2020
Reason
Lack of Assurance of Sterility
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-1033-2019, D-1017-2019, D-1023-2019, D-1026-2019, D-1031-2019, D-1022-2019, D-1029-2019, D-1018-2019, D-1021-2019, D-1032-2019, D-1025-2019, D-1027-2019 and 7 more

Terminated Class III Drugs

Recall started
6 February 2019
Terminated
30 October 2019
Reason
Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0498-2019, D-0499-2019, D-0497-2019

Terminated Class II Drugs

Recall started
6 February 2019
Terminated
30 October 2019
Reason
Labeling: Incorrect expiration date.
Distribution
PA
Initiated
Voluntary: Firm initiated
Recall number
D-0496-2019

Terminated Class II Drugs

Recall started
15 January 2019
Terminated
1 May 2019
Reason
Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)
Distribution
TX, WA
Initiated
Voluntary: Firm initiated
Recall number
D-0430-2019

Terminated Class I Drugs

Recall started
29 November 2018
Terminated
2 May 2019
Reason
Labeling: Label Error on Declared Strength: Label incorrectly lists concentration as "10 mcg per mL" rather than the correct concentration of "100 mcg per mL".
Distribution
Heath care facilities in NM, TX, and OH
Initiated
Voluntary: Firm initiated
Recall number
D-0347-2019

Terminated Class II Drugs

Recall started
20 June 2018
Terminated
3 April 2019
Reason
Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label.
Distribution
Distributed to one medical center in Fort Worth, TX.
Initiated
Voluntary: Firm initiated
Recall number
D-0889-2018

Terminated Class I Drugs

Recall started
5 January 2018
Terminated
5 September 2019
Reason
Subpotent
Distribution
Texas
Initiated
Voluntary: Firm initiated
Recall number
D-0575-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.